KVUE — Kenvue Inc.

NYSE · Materials · Chemicals · CIK 1944048 ·
Last close
$18.98
Market Cap
$36.46B
52W High
$20.13
52W Low
$16.67
ADV30
19,648,674
Next earnings
2026-11-05
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026 3,955,000,000 2,301,000,000 758,000,000 456,000,000 26,735,000,000 1,110,000,000 16,182,000,000
Mar 2026 3,909,000,000 2,302,000,000 838,000,000 474,000,000 26,854,000,000 1,075,000,000 16,246,000,000
Dec 2025 3,780,000,000 2,137,000,000 632,000,000 330,000,000 27,076,000,000 1,062,000,000 16,311,000,000
Sep 2025 3,764,000,000 2,226,000,000 713,000,000 398,000,000 27,248,000,000 1,139,000,000 16,614,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$2,325,000,000
Investing CF
$-424,000,000
Financing CF
$-1,861,000,000
CapEx
$-411,000,000
Dividends Paid
$-1,592,000,000
Buybacks
$-70,000,000
EPS Diluted TTM
$0.87
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-70,000,000
Inventory
$1,722,000,000
Receivables
$2,926,000,000
ST Investments
EBIT TTM
$2,648,000,000
Pretax Income TTM
$2,223,000,000
Interest Exp TTM
$425,000,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$15,408,000,000
EBITDA
$3,480,999,936
Free Cash Flow
$1,907,500,032
Enterprise Value
$43,959,279,616
Total Cash
$1,110,000,000
Total Debt
$8,613,000,192
Shares Out
1,920,773,467
Trailing EPS
$0.85
Book Value
$5.50
ROE
15.6%
ROA
7.0%
Div Yield
4.41%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 15,124,000,000 2,715,000,000 1,470,000,000 27,076,000,000 16,311,000,000 2,197,000,000
Dec 2024 15,455,000,000 2,629,000,000 1,030,000,000 25,601,000,000 15,933,000,000 1,769,000,000
Dec 2023 15,444,000,000 2,493,000,000 1,664,000,000 27,851,000,000 16,640,000,000 3,168,000,000
Dec 2022 14,950,000,000 2,688,000,000 2,064,000,000 27,316,000,000 7,346,000,000 2,525,000,000

TTM Snapshot

Revenues TTM
$11,603,000,000
NetIncome TTM
$1,407,000,000
OpCashFlow TTM
$0
Assets (Latest)
$25,601,000,000
Forward EPS
$1.24

Max Pain — expiry 2026-08-21

max pain strike: $19.00 · spot: $19.20 · call oi: 8,880 · put oi: 5,020
Expected Move to 2026-08-21: ±$0.45 (2.34%) — implied range $18.75$19.65 · ATM straddle on $19.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
NTR Nutrien Ltd. $32.06B $67.18
HLNCF Haleon plc $42.81B $4.86
HLN Haleon plc $43.16B $9.80
CTA-PA EIDP, Inc. $46.39B $53.46
PPG PPG INDUSTRIES INC $25.48B $114.60

News headlines (Yahoo Finance, 1h cache)

Kenvue Q2 Deep Dive: Assessing Financial Metrics & Growth Prospects
2026-08-12 17:31 · Yahoo
How Reddit and Wall Street See Kenvue as Buyout Nears
2026-08-07 12:45 · Yahoo
Kenvue Stock Falls 2.7% as Growth Arrives With Thinner Margins
2026-08-06 19:58 · Yahoo
Kenvue's Q2 Earnings Coming Up: Here's What Lies Ahead of the Stock
2026-07-31 17:22 · Yahoo
Kenvue's Brand Strength and Growth Drivers Shape Its Future Outlook
2026-07-29 14:38 · Yahoo
KVUE Q2 Earnings Miss Estimates as Margins Narrows, Sales Rise
2026-08-06 17:38 · Yahoo
Kimberly-Clark Appoints Suzana Blades as Senior Vice President and General Counsel
2026-08-13 13:25 · Yahoo
Kenvue second quarter results fall short of expectations, sending shares lower
2026-08-06 15:31 · Yahoo
Kenvue (KVUE) Lags Q2 Earnings and Revenue Estimates
2026-08-06 12:20 · Yahoo
Kenvue Reports Second Quarter 2026 Results
2026-08-06 10:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.